Life Biosciences is pushing cellular rejuvenation into the clinic with ER-100, an experimental gene ...

The first clinical attempt to make human beings biologically younger is no longer a thought experiment. A small gene therapy ...

Age-related memory decline and neurodegenerative diseases like Alzheimer's are often thought of as irreversible. But the brain is not static; neurons continually adjust the strength of their ...

A novel gene therapy that leads to cellular rejuvenation could restore vision after non-arteritic anterior ischemic optic neuropathy (NAION) and glaucoma. The technique is based on a reprogramming ...

"Aging has a relatively simple explanation and is apparently reversible." The post Scientists Testing Controversial Human Rejuvenation Compound Called ER-100 appeared first on Futurism.

ER-300 improves key biomarkers of liver health in an animal model of MASH These data, along with additional ER-100 preclinical data from a nonhuman primate model of NAION demonstrating clear ...

BOSTON, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Life Biosciences, Inc., (“Life Bio”) a biotechnology company pioneering cellular rejuvenation therapies to reverse and prevent multiple diseases of aging, ...

FDA agrees preclinical data support YB002 bioactivity and a future first-in-human trial in Alzheimer’s patients SEATTLE, Sept. 25, 2025 /PRNewswire/ — YouthBio Therapeutics, a biotechnology company ...

An international team led by researchers at Lund University in Sweden has identified the molecular tools needed to reprogram ordinary cells into specialized immune cells. The discovery, published in ...